ConductScience.org, home

Paper41550592

Ginsenoside Rg3-enriched red ginseng extract mitigates sepsis by inhibiting platelet-leukocyte aggregates and regulates thrombo-inflammatory pathways.

Lee YY and 8 others. J Ginseng Res, 2026. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Ginsenoside Rg3-enriched red ginseng extract mitigates sepsis by inhibiting platelet-leukocyte aggregates and regulates thrombo-inflammatory pathways. Papers, record 41550592. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41550592

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ginsenoside Rg3-enriched red ginseng extract mitigates sepsis by inhibiting platelet-leukocyte aggregates and regulates thrombo-inflammatory pathways.
PubMed
Journal
J Ginseng Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-01-21
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lee YYYuan Yee
2Akram AWAbdul Wahab
3Saba EEvelyn
4Chae HKHyung-Kyu
5Seo MGMin-Goo
6Kim SDSung Dae
7Park SJSang-Joon
8Kwak DDongmi
9Rhee MHMan Hee

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129686667Streptococcus agalactiae Non-Pilus, Cell Wall-Anchored Proteins: Involvement in Colonization and Pathogenesis and Potential as Vaccine Candidates.Front Immunol2018https://conductscience.org/library/papers/29686667PubMed
233641552Emerging therapeutic targets for sepsis.Expert Opin Ther Targets2021https://conductscience.org/library/papers/33641552PubMed
329021703Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation.J Ginseng Res2017https://conductscience.org/library/papers/29021703PubMed
433050789Endothelial cells, neutrophils and platelets: getting to the bottom of an inflammatory triangle.Open Biol2020https://conductscience.org/library/papers/33050789PubMed
529655000Platelet activation and antiplatelet therapy in sepsis: A narrative review.Thromb Res2018https://conductscience.org/library/papers/29655000PubMed
61872494The pathogenesis of sepsis.Ann Intern Med1991https://conductscience.org/library/papers/1872494PubMed
734688080Potential role of herbal medicines as a novel approach in sepsis treatment.Biomed Pharmacother2021https://conductscience.org/library/papers/34688080PubMed
838664775Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications.Cell Commun Signal2024https://conductscience.org/library/papers/38664775PubMed
934356636Inflammation and Cell Death of the Innate and Adaptive Immune System during Sepsis.Biomolecules2021https://conductscience.org/library/papers/34356636PubMed
1035058727Panax ginseng: Inflammation, platelet aggregation, thrombus formation, and atherosclerosis crosstalk.J Ginseng Res2022https://conductscience.org/library/papers/35058727PubMed
1140422802Dihydrogeodin from Fennellia flavipes Modulates Platelet Aggregation via Downregulation of Calcium Signaling, αIIbβ3 Integrins, MAPK, and PI3K/Akt Pathways.Mar Drugs2025https://conductscience.org/library/papers/40422802PubMed
1229053592Platelets and Multi-Organ Failure in Sepsis.Int J Mol Sci2017https://conductscience.org/library/papers/29053592PubMed
1335676565TLR4 inhibitor alleviates sepsis-induced organ failure by inhibiting platelet mtROS production, autophagy, and GPIIb/IIIa expression.J Bioenerg Biomembr2022https://conductscience.org/library/papers/35676565PubMed
1439583171The effects of Panax ginseng on growth enhancement, innate immunity, and microbiome profiling in Penaeus vannamei.J Ginseng Res2024https://conductscience.org/library/papers/39583171PubMed
1535398736Glaucocalyxin a protect liver function via inhibiting platelet over-activation during sepsis.Phytomedicine2022https://conductscience.org/library/papers/35398736PubMed
1639848591Disrupting the dangerous alliance: Dual anti-inflammatory and anticoagulant strategy targets platelet-neutrophil crosstalk in sepsis.J Control Release2025https://conductscience.org/library/papers/39848591PubMed
1740621083Ginsenoside Rg5 inhibits platelet aggregation by regulating GPVI signaling pathways and ferric chloride-induced thrombosis.J Ginseng Res2025https://conductscience.org/library/papers/40621083PubMed
1826950429Platelet-derived sphingosine-1-phosphate and inflammation: from basic mechanisms to clinical implications.Platelets2016https://conductscience.org/library/papers/26950429PubMed
1937817529The Role of Tissue Factor In Signaling Pathways of Pathological Conditions and Angiogenesis.Curr Mol Med2024https://conductscience.org/library/papers/37817529PubMed
2031315248Platelets Are Critical Key Players in Sepsis.Int J Mol Sci2019https://conductscience.org/library/papers/31315248PubMed

See all 47 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42878083Sepsis-associated endothelial dysfunction: clinical phenotypes, biomarkers, bedside evidence, and translational implications.J Clin Invest2026https://conductscience.org/library/papers/42878083PubMed
42719378Ginsenoside Rb1 ameliorates endothelial dysfunction in sepsis: Targeting the RhoA/ROCK pathway to modulate mitochondrial homeostasis and inflammation.J Ginseng Res2026https://conductscience.org/library/papers/42719378PubMed
42719336Ginsenosides Rh2 and Rg3 in first-line combination therapy: Prospects for rapid clinical translation in drug-resistant triple-negative breast cancer.J Ginseng Res2026https://conductscience.org/library/papers/42719336PubMed
42395025Ginsenosides from Panax ginseng: Their mechanisms, microbiome determinants, and translational strategies in therapeutic activity against cancer.J Ginseng Res2026https://conductscience.org/library/papers/42395025PubMed
42112128Ginsenoside Rs3 (G-Rs3) inhibits agonist- and oxLDL-mediated platelet activation and attenuates in vivo arterial thrombosis.J Ginseng Res2026https://conductscience.org/library/papers/42112128PubMed

Download CSV of cited by

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41550592

GET https://conductscience.org/api/papers/v1/41550592/references?page=2